University of Ottawa Health Innovation Hub

Ottawa firm inks deal to help Oxford Biomedica improve the yield and production efficiency of its next-generation gene therapies.
Company's revenues have more than doubled in the past year, and CEO expects headcount to grow from 16 to at least 30 by next year as demand for its products ramps up.